
In the ninth edition of the Peer Learning Series, ETILC members discussed the economic, social and personal implications of the second wave and what corporate India needs to do for the next one year. While, economically most businesses have a strategy in place to handle the current challenges, it is the mental and physical health of employees that is top of mind for Indian CEOs. The condition of those who work in the hospital and pharma industries is the worst as they are most fatigued in the current situation. Most ETILC members have established employee support networks to aid employees who are undergoing mental health issues. Companies have arranged for counsellors who employees can get in touch with free of charge and have also extended Covid insurance to employees and channel partners.
Leaders from the health industry are emphasizing that it is key to prepare employees for what lies ahead. Covid-19 will continue to remain a reality for the next year or so.
The cases in Delhi are currently very high and it is being predicted that the situation will also worsen in Bengaluru and Chennai. Even though vaccination is important it is not the final cure that most are expecting it to be. One cannot expect to take two doses of a vaccine and expect that everything will go back to normal. While the second wave will subside shortly across the country and the economy will open up again, it is inevitable that there will be a third wave.
For the next three months, the focus of the central government is on two vaccines - Covaxin and Covishield. However, by Q3, more vaccines will be available in the Indian market and the volume of vaccines July onward is expected to be 15 crores/month. By December 2021, healthcare professionals estimate that India would have procured a total of 120 crore vaccines and 60 crore individuals would be vaccinated. If the procurement pace can be further improved, India can reach the target of 100 crore people getting vaccinated - which is what is ideal for a nation with a population of a billion people.
Testing
There are some cases where an individual could test negative for Covid-19 even after doing an RT-PCR test and continue to show symptoms. This is most likely not a fault with the test itself. Because of the pressure on the health system and the large number of tests being done, sample collection is compromised. Also, the viral transport media in which you store the sample has a limited shelf life. Thus, if there is contamination anywhere, it could compromise the results.
Medication Myths Busted
Top healthcare executives in the ETILC member group have also advised against falling prey to medication myths linked to Covid-19 cures.
Recommendations:
Action By Corporate India
Private companies are contributing as much as possible to ease the current situation. Bharat Serums and Vaccines (BSV) for instance is focused on pushing vaccination drives and is adopting villages in addition to getting employees and their families vaccinated. Another focus area for BSV is putting up oxygen manufacturing plants within hospital facilities taking into account the current challenges of oxygen transportation due to a paucity of containers and logistical issues.
Parexel which conducts clinical trials on behalf of its pharmaceutical clients has not got its over five thousand employees back to work in over 12 months. The company is having discussions with multiple healthcare integrators to increase vaccination and add to what the government is trying to do in addition to tackling immediate employee requirements.
While business continuity plans are easy to execute this time, it is medical care and fatalities that corporate India was unprepared to deal with at the current level. Many organizations are focusing on being apolitical and focusing on the right communication.
Duroflex, a leading player in the Indian mattress industry has set up an employee assistance program through which employees can access one-on-one sessions with healthcare professionals to discuss personal issues. The program has now been running for many months and has been found to be effective. The organization has also decided to turn FY2021 into a 11-month business year with employee welfare as a key focus area. The brand is also expanding the Duroflex Cares initiative where they offer expert advice from doctors, tips to manage covid related anxiety and resultant sleep issues, free consultations with sleep doctors and much more to support people. The company has also set up a special CSR task force for donating mattresses, ventilators and concentrators to Covid care facilities across the country
Henkel India is encouraging Covid-19 appropriate behavior and not asking its close to 1000 employees to step out of the house for work. GMR Group is seeing that involving employees in CSR activities has had a positive impact.
Many organizations are donating ventilators and oxygen cylinders. Companies are saying there is plenty of capability to produce oxygen, the main issue is in transportation as cylinders and trucks are in short supply.
Pregnant Mothers and Under 18
USFDA has already approved vaccination for pregnant mothers and vaccination for under 18 will soon be approved. This is the standard procedure followed with vaccine approvals, once the 18-45 results are seen, the under 18 trials begin. For six vaccines the trials for 12-18 age group are close to being done.
Responsible Communication
CEOs are mindful that there is plenty of misinformation and fake news about new facilities and cures going around and are spending time on communicating more with their employees and passing on only verified information.
Leaders from the health industry are emphasizing that it is key to prepare employees for what lies ahead. Covid-19 will continue to remain a reality for the next year or so.
The cases in Delhi are currently very high and it is being predicted that the situation will also worsen in Bengaluru and Chennai. Even though vaccination is important it is not the final cure that most are expecting it to be. One cannot expect to take two doses of a vaccine and expect that everything will go back to normal. While the second wave will subside shortly across the country and the economy will open up again, it is inevitable that there will be a third wave.
For the next three months, the focus of the central government is on two vaccines - Covaxin and Covishield. However, by Q3, more vaccines will be available in the Indian market and the volume of vaccines July onward is expected to be 15 crores/month. By December 2021, healthcare professionals estimate that India would have procured a total of 120 crore vaccines and 60 crore individuals would be vaccinated. If the procurement pace can be further improved, India can reach the target of 100 crore people getting vaccinated - which is what is ideal for a nation with a population of a billion people.
Testing
There are some cases where an individual could test negative for Covid-19 even after doing an RT-PCR test and continue to show symptoms. This is most likely not a fault with the test itself. Because of the pressure on the health system and the large number of tests being done, sample collection is compromised. Also, the viral transport media in which you store the sample has a limited shelf life. Thus, if there is contamination anywhere, it could compromise the results.
Medication Myths Busted
Top healthcare executives in the ETILC member group have also advised against falling prey to medication myths linked to Covid-19 cures.
Recommendations:
Action By Corporate India
Private companies are contributing as much as possible to ease the current situation. Bharat Serums and Vaccines (BSV) for instance is focused on pushing vaccination drives and is adopting villages in addition to getting employees and their families vaccinated. Another focus area for BSV is putting up oxygen manufacturing plants within hospital facilities taking into account the current challenges of oxygen transportation due to a paucity of containers and logistical issues.
Parexel which conducts clinical trials on behalf of its pharmaceutical clients has not got its over five thousand employees back to work in over 12 months. The company is having discussions with multiple healthcare integrators to increase vaccination and add to what the government is trying to do in addition to tackling immediate employee requirements.
While business continuity plans are easy to execute this time, it is medical care and fatalities that corporate India was unprepared to deal with at the current level. Many organizations are focusing on being apolitical and focusing on the right communication.
Duroflex, a leading player in the Indian mattress industry has set up an employee assistance program through which employees can access one-on-one sessions with healthcare professionals to discuss personal issues. The program has now been running for many months and has been found to be effective. The organization has also decided to turn FY2021 into a 11-month business year with employee welfare as a key focus area. The brand is also expanding the Duroflex Cares initiative where they offer expert advice from doctors, tips to manage covid related anxiety and resultant sleep issues, free consultations with sleep doctors and much more to support people. The company has also set up a special CSR task force for donating mattresses, ventilators and concentrators to Covid care facilities across the country
Henkel India is encouraging Covid-19 appropriate behavior and not asking its close to 1000 employees to step out of the house for work. GMR Group is seeing that involving employees in CSR activities has had a positive impact.
Many organizations are donating ventilators and oxygen cylinders. Companies are saying there is plenty of capability to produce oxygen, the main issue is in transportation as cylinders and trucks are in short supply.
Pregnant Mothers and Under 18
USFDA has already approved vaccination for pregnant mothers and vaccination for under 18 will soon be approved. This is the standard procedure followed with vaccine approvals, once the 18-45 results are seen, the under 18 trials begin. For six vaccines the trials for 12-18 age group are close to being done.
Responsible Communication
CEOs are mindful that there is plenty of misinformation and fake news about new facilities and cures going around and are spending time on communicating more with their employees and passing on only verified information.
(Disclaimer: The opinions expressed in this column are that of the writer. The facts and opinions expressed here do not reflect the views of www.economictimes.com.)
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.